WORKSHOP: Biomarker Assay Development and Validation
WORKSHOP: microRNA as Cancer Biomarkers
Third Annual Genomic Biomarkers
Fifth Annual Protein Biomarkers
Eighth Annual Metabolic Biomarkers
Third Annual Toxicity Biomarkers
- Systems Biology in Biomarker Discovery
- Biomarker Validation
- Biomarkers in Clinical Trials
- Protein Biomarker Discovery
- Biomarker Data Analysis
- Toxicity Biomarker Discovery
- Cancer Biomarkers
John L. Allinson, FIBMS, Director, Veeda Clinical Research Ltd.
Carrie Brodmerkel, Ph.D., Assistant Director, Clinical Pharmacology and Experimental Medicine, Centocor R&D
George Calin, Ph.D., Assistant Professor, Molecular Virology, Immunology and Molecular Genetics, Ohio State University
Mark Chance, Ph.D., Director, Center for Proteomics, Case Western Reserve University
Jinzhi Chen, Ph.D., Head, Genetics/Genomics, Proteomics/Biomarker Discovery, Roche Palo Alto
Frances Clemo, DVM, Ph.D., Research Fellow, Drug Safety Research & Development, Pfizer Inc.
Dalia Cohen, Ph.D., Executive Vice President, Head, Research and Development, Rosetta Genomics
Viswanath Devanarayan, Ph.D., Director, Statistics, Biomarker Research, Abbott Laboratories
Darius Dziuda, Ph.D., Assistant Professor, Mathematics, Central Connecticut State University
Giora Feuerstein, M.D., Assistant Vice President, Head, Discovery Translational Medicine, Wyeth Research
Stephen Furlong, Ph.D., Director, Discovery Medicine, AstraZeneca
Neil Gibson, Ph.D., Research and Development Genetics, AstraZeneca
Michael Hamilton, M.D., Chief Medical Officer, Avalon Pharmaceuticals
William Hancock, Ph.D., Bradstreet Chair, Barnett Institute, and Department of Chemistry and Chemical Biology, Northeastern University
Alan Higgins, Ph.D, Senior Director, Translational Medicine, Cogenics, Inc., a division of Clinical Data Inc.
Irena Ivanovska, Ph.D., Senior Research Biologist, Rosetta Inpharmatics, A wholly owned subsidiary of Merck & Co., Inc.
Sunil Kadam, Ph.D, Research Advisor, Genomic Medicine, Eli Lilly and Co.
Rima Kaddurah-Daouk, Ph.D., Associate Professor, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center
Jill M. Kolesar, Pharm.D., Associate Professor, Pharmacy, University of Wisconsin-Madison
Emmanuel Labourier, Ph.D., Director of Development, Asuragen Inc.
Jae K. Lee, Ph.D., Associate Professor, Biostatistics, University of Virginia School of Medicine; and Director, UVA Bioinformatics Support Core
Jean Lee, Ph.D., Scientific Director, PKDM, Amgen Inc.
Richard A. Lempicki, Ph.D., LIB Lab Head, Senior Scientist, Clinical Services Program, Laboratory of Immunopathogenesis and Bioinformatics, SAIC-Frederick, Inc.
Brian Luke, Ph.D., Senior Scientist, Advanced Biomedical Computing Center, National Cancer Institute
William B. Mattes, Ph.D., Director, Toxicology, The Critical Path Institute
Søren Møller, Ph.D., Chief Scientific Officer, Vice President, R&D, Exiqon A/S
Stephen Naylor, Ph.D., Chairman and Chief Executive Officer, Predictive Physiology and Medicine Inc.
Eustache Paramithiotis, Ph.D, Director, Molecular and Cellular Biology, Caprion Pharmaceuticals
Emanuel F. Petricoin, Ph.D., Co-Director, Center for Applied Proteomics and Molecular Medicine; and Professor of Life Sciences, George Mason University
Reena Philip, Ph.D., Scientific Reviewer, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, U.S. Food and Drug Administration
J. Suso Platero, Ph.D., Group Leader, Clinical Biomarker Development, Bristol-Myers Squibb
Daniel Raftery, Ph.D., Professor, Chemistry, Purdue University
Koustubh Ranade, Ph.D., Director, Pharmacogenomics & Human Genetics, Pharmaceutical Research Institute, Bristol-Myers Squibb Company
Laura K. Schnackenberg, Ph.D., Staff Fellow, Division of Systems Toxicology, National Center for Toxicological Research, Food and Drug Administration
Peter Schulz-Knappe, Ph.D., Chief Scientific Officer, Proteome Sciences plc
Natalie J. Serkova, Ph.D., Associate Professor, Anesthesiology and Radiology, Cancer Center MRI/MRS Core, University of Colorado Health Sciences Center
Vladimir Shulaev, Ph.D., Associate Professor, Virginia Bioinformatics Institute
John J. Sninsky, Ph.D., Vice President, Discovery Research, Celera Diagnostics
Vladimir Tolstikov, Ph.D., Director, Metabolomics Core, University of California, Davis Genome Center
Weida Tong, Ph.D., Director, Center for Toxicoinformatics, National Center for Toxicological Research, FDA
Kevin Wang, Ph.D., Associate Director, Center for Traumatic Brain Injury Studies (CTBIS); Director, Center for Neuroproteomics and Biomarkers Research (CNBR); and Associate Professor of Psychiatry and Neuroscience, Department of Psychiatry, McKnight Brain Institute, University of Florida
Mu Wang, Ph.D., Assistant Professor, Biochemistry and Molecular Biology and Adjunct Assistant Professor, Informatics, Indiana University School of Medicine; and Director, Protein Analysis Research Center, The Indiana Centers for Applied Protein Sciences (INCAPS)
Hans Winkler, Ph.D., Senior Director, Functional Genomics, Johnson and Johnson Pharmaceutical R&D
Qiuwei Xu, Ph.D., Merck Research Laboratories